about
Chronic lymphocytic leukemia: a clinical review including Korean cohortsChallenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological MalignancyNext-generation surveillance strategies for patients with lymphomaExtranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.Increased risk for metachronous gastric adenocarcinoma following gastric MALT lymphoma-A US population-based study.Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.Characteristics of TCRζ, ZAP-70, and FcɛRIγ gene expression in patients with T- and NK/T-cell lymphomaNoninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update.Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric NanomedicinesComparison of Three Chemotherapy Regimens in Elderly Patients with Diffuse Large B Cell Lymphoma: Experience at a Single National Reference Center in Mexico.Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience.GATA3 expression correlates with poor prognosis and tumor-associated macrophage infiltration in peripheral T cell lymphomaSurveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.Hematopoietic progenitor cell mobilization for autologous transplantation - a literature review.The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma.Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database.The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients.Design of smart HPMA copolymer-based nanomedicines.Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.Bowel perforation from occult ileal involvement after diagnosis in a case of primary mediastinal large B-cell lymphoma.Haemodynamic instability secondary to cardiac involvement by lymphoma.Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma.Treatment patterns and outcomes with subcutaneous bortezomib in patients with relapsed mantle cell lymphoma: a retrospective, observational study of patient medical records from US community oncology practices.Older patients with early-stage diffuse large B-cell lymphoma: the role of consolidation radiotherapy after chemoimmunotherapy.Time, timing, and the treatment of diffuse large B-cell lymphoma.Metabolic tumor volume changes assessed by interval 18fluorodeoxyglucose positron emission tomography-computed tomography for the prediction of complete response and survival in patients with diffuse large B-cell lymphoma.Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.
P2860
Q26752467-CEAC14E8-8E5F-4DF6-A5E9-8C63772F5A04Q28080304-10FF1294-7016-4D3E-93A5-7741FA86A565Q28084956-E202917B-FA79-42ED-9ECA-1E3DE5A23BE4Q30244110-CB7B951C-B165-4FF9-996F-FCFB93AF6871Q31110269-A9605A1A-4CB5-44ED-AA05-5470EFDD4785Q33732016-5BAD4B1D-FEDD-4E1A-AE5D-8AFF2866DDA5Q33851726-F5F538A1-2890-41BF-94BA-094932FCB260Q35110756-AB76A73A-932B-446A-8720-CF5110BF783DQ35723986-52539754-0FDA-4C71-BE4A-FB1C10DC4E23Q35771194-CB4291CB-033B-4924-8A13-834E8D484EEEQ35861726-71F26D42-2937-427F-B0F5-A045A9279410Q37120684-8ED0ADBD-C2FF-4D91-8DEB-8CC6BA2637B4Q37607286-B6C45376-81D3-45A7-8389-D04CC12167B5Q37662219-E26FA277-6475-475C-8CD4-8EF762F5C4B2Q38630219-75975EE4-6CAF-49DF-ACDA-12D3DEBBA55AQ38771080-A7E39D36-A065-4460-A7B1-3B0FF5D00BF3Q38856104-305CFBEB-2C00-43FE-9156-1E72064969BCQ39045701-D3F2A766-3430-44AB-9582-3B3A1BB43E77Q39353147-1083ED02-329C-4768-B888-BCAF4D840E85Q39669214-0BC32575-C1C7-4EBB-AC6C-04006D4D950FQ41471555-455A90B1-6C7C-4D6E-AC05-A025D7466F6AQ42553783-917573C1-AF55-44D2-87B5-D82BBEFF9127Q47830676-39C19F61-B660-49E3-BA59-0BBD04F8F624Q48158787-025A07BB-CC6F-4D3D-A0C4-69543416317AQ51289951-7CA48146-317A-4304-BB61-8A7C1F57888AQ51824124-E559C7DD-4DEE-4EEA-8A19-7A2BF0A04402Q52802238-00E84E61-63A1-4AA2-982F-A7CD4CD75A93Q53019638-84105B13-A47B-4F1E-B10F-FDDE5F10647FQ53435280-96725442-5E5C-497D-AB4C-FC55EB626ABFQ55660635-03826004-D18A-43F0-8052-006A62D4A99DQ55717193-BBC662FB-A4EC-4762-B116-D5713206A1C4
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Non-Hodgkin's lymphomas, version 4.2014.
@en
type
label
Non-Hodgkin's lymphomas, version 4.2014.
@en
prefLabel
Non-Hodgkin's lymphomas, version 4.2014.
@en
P2093
P2860
P50
P356
P1476
Non-Hodgkin's lymphomas, version 4.2014.
@en
P2093
Andrew D Zelenetz
Ann S LaCasce
Auayporn Nademanee
Ayman A Saad
C Babis Andreadis
Christina Tsien
Christopher R Kelsey
Hema Sundar
Jeremy S Abramson
P2860
P304
P356
10.6004/JNCCN.2014.0125
P577
2014-09-01T00:00:00Z